Mechanical Ventilator Market (2026 - 2033)

Mechanical Ventilator Market Summary

The global mechanical ventilator market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.4 billion in 2026 to USD 5.5 billion by 2033, at a CAGR of 7.1% from 2026 to 2033. North America held the largest global revenue share of 41.6% in 2025. The increasing prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, asthma, obstructive sleep apnea, exertional dyspnea, and pulmonary embolism is fueling the growth of the mechanical ventilator industry.

Market Dynamics

Market Concentration & Characteristics

The mechanical ventilator market is currently experiencing moderate growth at an accelerating pace, propelled by factors including a growing geriatric population, a substantial patient pool with respiratory disorders, and the introduction of technologically advanced devices.

In the mechanical ventilator industry, a noteworthy emphasis has been placed on innovation to enhance patient comfort, compliance, efficacy, and overall treatment outcomes. The integration of smart technology and digital sensors plays a pivotal role in augmenting therapy management, contributing significantly to the market's momentum.

The mechanical ventilator market is witnessing an upswing in mergers and acquisitions, with companies strategically pursuing multiple acquisitions to bolster product portfolios, expand their global presence, diversify offerings, integrate technologies, and strengthen their positioning in the industry.

Companies in the market are expanding into new regional markets to strengthen their customer base, enhance distribution networks, and capitalize on growing demand for critical care and respiratory support solutions. For instance, in March 2026, Mindray North America entered the U.S. ventilator market with the launch of the SV300 and SV600 ventilators, expanding its respiratory care portfolio and strengthening its presence in North America's critical care segment. Such expansion initiatives are supporting market growth and increasing global access to advanced ventilation technologies.

Analyst Perspective

The mechanical ventilators market is relatively mature across developed healthcare systems, particularly in North America and Europe; however, significant growth opportunities remain supported by the rising prevalence of chronic respiratory diseases, increasing critical care admissions, and the growing burden of respiratory failure associated with aging populations. Market expansion is being driven by technological advancements such as intelligent ventilation modes, enhanced patient monitoring capabilities, improved portability, and integration with hospital information systems, which improve clinical outcomes and operational efficiency.

In addition, increasing investments in critical care infrastructure, expanding access to healthcare services in emerging economies, and the growing adoption of home-based ventilation for long-term respiratory support are expected to support sustained market growth. As competition intensifies, manufacturers are likely to focus on product innovation, connectivity-enabled ventilation platforms, regulatory compliance, and geographic expansion to strengthen their market position and capitalize on emerging opportunities across both acute and chronic respiratory care settings.

Interphase Insights

The non-invasive ventilators segment dominated the mechanical ventilator industry, accounting for the largest share of 58.1% in 2025. The segment’s growth can be attributed to the ventilators’ wide range of applications and the ability to deliver precise, higher concentrations of oxygen. The delivery of non-invasive ventilation is made possible with advanced intensive care ventilators that offer various respiratory support modes.

The invasive ventilators segment also held a significant market share in 2025. The large share can be attributed to the critical role of invasive mechanical ventilation in managing severe respiratory failure, acute respiratory distress syndrome (ARDS), post-surgical respiratory support, trauma cases, and critically ill patients requiring precise and continuous ventilatory assistance.

Ventilation Mode Insights

The CPAP ventilation mode segment of the non-invasive mechanical ventilators market, accounting for the largest share of 66.5% in 2025. The segment's dominance is primarily driven by the widespread adoption of CPAP therapy as the first-line non-invasive respiratory support for conditions such as obstructive sleep apnea (OSA), COPD exacerbations, acute cardiogenic pulmonary edema, and hypoxemic respiratory failure.

Moreover, the BiPAP ventilation mode segment is anticipated to grow at the fastest CAGR during the forecast period. The growth of the segment is attributed to the increasing prevalence of chronic respiratory disorders such as COPD, obesity hypoventilation syndrome, and neuromuscular diseases that require varying inspiratory and expiratory pressure support. BiPAP offers enhanced ventilatory support, improved carbon dioxide clearance, greater patient comfort, and improved tolerance for patients with moderate-to-severe respiratory insufficiency.

Indication Insights

In 2025, the COPD segment of the non-invasive mechanical ventilators industry held the largest share, owing to the high global prevalence of chronic obstructive pulmonary disease and the widespread clinical adoption of non-invasive ventilation as a standard-of-care treatment for acute exacerbations and chronic hypercapnic respiratory failure.

The neuromuscular diseases segment of the non-invasive mechanical ventilators market is expected to grow at the fastest CAGR from 2026 to 2033, owing to the increasing prevalence and diagnosis of chronic neuromuscular disorders that impair respiratory muscle function, such as Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy. Growing clinical preference for long-term non-invasive ventilation to delay disease progression, improve quality of life, reduce hospitalizations, and avoid tracheostomy-related complications is driving adoption.

Regional Insights

North America dominated the mechanical ventilator market with a revenue share of over 41.6% in 2025. The increasing prevalence of respiratory conditions, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea, is driving the therapeutic respiratory devices market in the region.  According to the American Lung Association, 11.7 million people, which is 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema in 2022. Moreover, key market players, such as GE Healthcare; CAIRE, Inc.; Koninklijke Philips N.V.; Invacare; Medtronic; and React Health, employ strategies, such as acquisitions, collaborations, expansions, and new product launches, to extend their product offerings and geographical reach.

U.S. Mechanical Ventilator Market Trends

The U.S. mechanical ventilator industry’s growth is driven by several key factors, including a high prevalence of chronic respiratory diseases such as COPD and asthma, an aging population, and advancements in healthcare infrastructure. According to an article published by the American Lung Association in February 2023, over 34 million U.S. individuals suffer from chronic lung diseases, including COPD, asthma, chronic bronchitis, and emphysema. The COVID-19 pandemic has also heightened the demand for ventilators, leading to rapid innovation and production scaling. Advanced technologies such as AI are being integrated into monitoring and predictive analytics, and portable ventilator models are being developed for various healthcare settings.

Europe Mechanical Ventilator Market Trends

The Europe mechanical ventilator industry, particularly in the UK, is shaped by stringent regulatory requirements, technological advancements, and a growing elderly population. There is a notable emphasis on developing ventilators that are energy-efficient, environmentally friendly, and capable of providing personalized patient care. The Medical Device Regulations (MDR), which came into effect in May 2021, harmonizes the regulation of medical devices across the European Union (EU). It sets stringent requirements for the safety, performance, and quality of mechanical ventilators and other medical devices. Manufacturers must comply with detailed technical documentation, clinical evaluation, and post-market surveillance requirements to obtain and maintain CE marking.

Asia Pacific Mechanical Ventilator Market Trends

The mechanical ventilator industry in Asia Pacific is expected to grow at a significant CAGR of 9.2% over the forecast period. The growth can be attributed to the high burden of respiratory disorders and the high risk of lifestyle factors such as smoking and allergies, resulting in several respiratory conditions. According to the World Health Organization, China has one of the highest smoking populations in the world, with over 300 million smokers, contributing significantly to respiratory health issues. This has driven a robust demand for mechanical ventilators capable of providing both invasive and non-invasive ventilation support. Additionally, government initiatives to boost ventilator production and manufacturer collaborations to develop advanced ventilators to meet high demand are propelling the region’s growth.

The mechanical ventilator market in Japan is anticipated to grow over the forecast period, due to the demand for advanced ventilator technologies that improve patient outcomes and operational efficiency, driven by an aging population and high healthcare standards in the region.According to the Population Reference Bureau in 2021, over 28% of Japan's population was aged 65 or older, creating a substantial demand for healthcare solutions addressing age-related respiratory conditions and critical care needs. This demographic shift compels healthcare providers to adopt advanced ventilators with features such as non-invasive ventilation modes, high-flow oxygen therapy, and integrated monitoring systems to enhance patient care and manage complex respiratory cases more effectively.

Key Companies & Market Share Insights

The competitive landscape of the mechanical ventilator market features key players such as ResMed, Koninklijke Philips N.V., and Fisher & Paykel Healthcare. These industry leaders are actively engaged in strategic initiatives, including mergers and acquisitions, to strengthen their market positions.

A notable example is the partnership formed in August 2023 between Medline, a prominent U.S.-based medical supplies and devices manufacturer, and Flight Medical, an Israeli respiratory device manufacturer. Within this collaboration, Medline exclusively offers the Flight 60 transportable ventilator. This advanced device seamlessly transitions between invasive and non-invasive ventilation modes to meet the ventilation needs of high-acuity patients. Notably, the ventilator's portability and durability make it suitable for a diverse range of patients, from pediatric to adult cases.

“This collaboration will make an impact in addressing ventilator availability in the industry and, most importantly, help our providers improve patient care. By joining forces with Flight Medical, we strengthen our respiratory portfolio to meet the needs of customers across the continuum of care.”

- Brian Groskopf, Senior Director, Product Management, Medline

Key Companies & Market Share Insights in Other Relatable Respiratory Devices

Oxygen Concentrators

Key players in the mechanical ventilator market employ various strategies, including mergers and acquisitions, product launches, expansion into emerging economies, and enhancing service networks, to strengthen their market positions. For instance,

• In January 2023, CAIRE Inc., a global manufacturer of oxygen therapy and on-site generation systems, acquired MGC Diagnostics Holdings, Inc., a company headquartered in St. Paul, Minnesota. The acquisition strengthened CAIRE's presence in, and commitment to, diagnostic technologies, further enhancing its ability to serve patients at all stages of pulmonary disease progression.

• In November 2022, CAIRE Inc.’s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company expanded its oxygen therapy modalities product portfolio through this launch.

Exit Strategies of Key Market Player

Medtronic

• In October 2022, Medtronic decided to separate its respiratory interventions (PMRI) and patient monitoring businesses from the ventilator market. The decision was made due to the company's significant expansion during the COVID-19 pandemic, which led to ventilator shortages.

• Later, Medtronic recognized that the spinoff plan no longer benefited the firm. Therefore, in February 2024, Medtronic announced its intention to exit the ventilator business and merge its Patient Monitoring and Respiratory Interventions (PMRI) segments into a new unit called Acute Care and Monitoring (ACM).

  

Medtronic Strategy

• Despite ceasing new sales, Medtronic will continue to honor existing contracts for ventilators. This ensures that their current customers and patients relying on these devices are not abruptly affected.

• By discontinuing the unprofitable ventilator line, Medtronic reallocated resources, both financial and operational, to other segments within the ACM unit. This move is expected to enhance investment in areas with better growth potential and higher profitability.

Koninklijke Philips N.V.

• In January 2024, Koninklijke Philips N.V. announced the discontinuation of select respiratory products in the U.S. and its territories, including the ventilators, SimplyGo Mini, SimplyGo, and Everflo oxygen concentrators. The landscape of ventilators market is poised for notable shifts. According to a survey poll conducted by HME News in February 2024, approximately 70% of respondents assert that Philips' decision to withdraw from a substantial portion of the U.S. respiratory market will wield considerable influence on the industry.

• While the discontinuation of respiratory products by Philips Respironics signifies a significant development in the oxygen concentrator market, it also presents opportunities for other market players to innovate and expand their presence.

Key Mechanical Ventilator Companies

The following key companies have been profiled for this study of the mechanical ventilator market.

• ResMed

• Fisher & Paykel Healthcare

• Drägerwerk AG & Co. KGaA

• Getinge AB

• Air Liquide Medical Systems

• GE HealthCare

• Hamilton Medical

• Smiths Medical

• Bio-Med Devices

• ZOLL Medical Corporation

• aXcent Medical GmbH

• Magnamed

• Avasarala Technologies Limited

• Airon Corporation

• HEYER Medical AG

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Nihon Kohden Corporation

• Schiller AG

Competitive Benchmarking

Recent Developments

• In December 2025, Vapotherm and Flight Medical announced a strategic partnership to introduce the VentO2ux ventilator to U.S. hospitals, expanding Vapotherm’s respiratory care portfolio beyond high-velocity therapy. The compact, lightweight ventilator is designed for critically ill patients and combines advanced ventilation performance, portability, and ease of use, particularly for emergency and critical care settings.

• In June 2025, Getinge announced the expansion of its Servo-c ventilator platform with a dedicated neonatal ventilation option, enabling support for premature and newborn patients. The enhancement extends the ventilator’s usability to a broader patient population, providing advanced respiratory support across neonatal to adult care settings.

“Hospitals are under increasing pressure to deliver high-quality care for diverse patient needs while managing costs. Servo-c now supports this by enabling personalized respiratory treatment across all patient categories from premature newborns to full grown adults with full flexibility in targeted markets. This is part of our commitment to make life-saving technology accessible for more people,”

 - Cecilia Sjöstedt, Vice President Critical Care at Getinge.

• In June 2024, Air Liquide Medical Systems launched the Monnal TEO resuscitation ventilator, a new ICU ventilator designed and manufactured in France for critical care and intensive care settings. Developed in collaboration with clinicians, the ventilator incorporates advanced monitoring, respiratory physiology assessment tools, and personalized ventilation capabilities to support the management of patients with acute respiratory failure.

Mechanical Ventilator Market Report Scope

Global Mechanical Ventilator Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the mechanical ventilator market report based on interphase, and region:

• Interphase Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Invasive

    • Product Type

      • Ventilators

      • Accessories

    • End use

      • Critical care

      • Others

  • Non-invasive

    • Product Type

      • Ventilators

        • Product Type

          • Critical Care

          • Neonatal

          • Transport & Portable

          • Others

        • End use

          • Acute care

          • Post-acute

          • Home care

          • Critical care

      • Accessories

• Non-Invasive Ventilation Mode Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • CPAP

  • BiPAP

  • Others

• Non-Invasive Indication Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • COPD

  • Neuromuscular diseases

  • Others

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Russia

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The mechanical ventilator market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each mechanical ventilator segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations